Drug
MK 1406
MK 1406: highest development phase Phase 3, developed by Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA). 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Trials
| Drug | Phase | Indication |
|---|---|---|
| MK-1406 NCT07159763 | Phase 3 | Influenza |
Latest
No recent events.
Follow MK 1406 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.